Search

everythinglearnresearchcommunity

for

Search:↓

The FDA warned about safety issues with remdesivir and tofacitinib, finasteride is linked to suicidality, potent topical corticosteroids increase osteoporosis risk, henna can cause hemolysis in G6PD deficiency, chemotherapeutic agents can cause adverse reactions, drug interactions are common in cancer patients, ketamine can reduce at-risk drinking, high dose of anticholinergics increases dementia risk in Parkinson's patients, and prenatal exposure to second-generation antipsychotics increases pregnancy complications.

Sodium valproate caused vomiting, hair loss, loss of appetite, abdominal pain, weight gain, and anemia in young children with epilepsy.

Modified HDL can better deliver drugs and genes, potentially improving treatments and reducing side effects.

Botulinum toxin type A significantly reduces scalp psoriasis severity compared to placebo.

The summit aimed to speed up finding treatments for alopecia areata.

Aldesleukin can treat certain cancers and increase HIV patient CD4+ counts but often causes severe side effects.

Effective treatments for scalp psoriasis include glucocorticosteroids, Vitamin D3 analogs, and combination therapies like calcipotriol and betamethasone dipropionate.

The meeting highlighted the genetic basis of female pattern hair loss and various skin health insights.

Taking calcium may help elderly with osteoporosis, birth control with levonorgestrel doesn't increase heart attack risk, Salmonella can cause arthritis, a national ethics committee is recommended, and sulfasalazine might help with a hair loss condition.

Sequential therapy with dupilumab and baricitinib improved hair regrowth and atopic dermatitis in a child without adverse reactions.

COVID-19 may be linked to hair loss or worsening of hair loss in some people.

The analysis found that alopecia areata, a hair loss condition, is not very common in Australia, affecting about 0.13% of people, with new cases most often seen in males aged 19 to 34 years.

Low vitamin D levels are linked to severe and active alopecia areata.

Certain genes on chromosomes 6, 10, 16, and 18 may increase the risk of alopecia areata.

Low Vitamin D is common in people with Alopecia Areata, but its impact on the condition needs more research.

Tofacitinib successfully treated hair loss in a Crohn's disease patient who previously used adalimumab.

English springer spaniels are more prone to severe sebaceous adenitis than standard poodles.

A woman's complete hair loss condition improved after recovering from COVID-19.

Patients with rheumatoid arthritis using tofacitinib had more serious side effects than those with alopecia areata.

Baricitinib helps regrow hair in adults with severe alopecia better than a placebo and is approved for treatment, but long-term effects are still unknown.

A girl with Evans' syndrome had her low platelet count successfully treated with zanubrutinib.

Intralesional triamcinolone acetonide is better than PRP for treating scalp alopecia areata, leading to faster and more complete hair regrowth.

Blocking JAK3 signaling can reverse hair loss from alopecia areata.

A woman with severe hair loss was successfully treated with the drug adalimumab.

Childhood Alopecia Areata causes hair loss and requires varied treatments, with psychological support being crucial.

Different methods, including stress management, healthy diet, supplements, and treatments like minoxidil, can help hair grow back after COVID-19 related hair loss.

Alopecia areata needs more recognition and better treatment access in Latin America to improve patient care and outcomes.

JAK inhibitors can effectively reverse hair loss in people with alopecia areata.

Certain IL-18 gene variations may increase the risk of alopecia areata.

A young woman with severe symptoms of CPAN improved with intensive treatment but needed a leg amputation.